Recommended Immunization Schedule for a 19-Year-Old Without Documentation
A healthy 19-year-old in the United States without immunization records should be assumed unvaccinated and receive all age-appropriate vaccines immediately without waiting for serologic testing, as administering vaccines to previously immunized individuals poses no additional risk. 1
Core Vaccines Required for All 19-Year-Olds
Tetanus, Diphtheria, and Pertussis (Tdap/Td)
- Administer one dose of Tdap immediately, followed by Td boosters at 4 weeks and 6-12 months to complete the primary 3-dose series. 1
- After completing the primary series, give Td boosters every 10 years. 2
Influenza
- Give one dose of inactivated influenza vaccine (IIV) or live attenuated influenza vaccine (LAIV) annually. 2
- This is recommended for all adults regardless of age or risk factors. 1
Hepatitis B
- Administer a 2-dose series of HEPLISAV-B at 0 and 1 month, or a 3-dose series of ENGERIX-B/Recombivax HB at 0,1, and 6 months. 1
- Universal hepatitis B vaccination is now recommended for all adults aged 19-59 years. 1
Measles, Mumps, and Rubella (MMR)
- Give a 2-dose series of MMR at least 4 weeks apart if born in 1957 or later without documentation of vaccination or laboratory immunity. 2, 1
- Two doses are required for healthcare workers and other high-risk adults; one dose may suffice for average-risk individuals. 1
Varicella
- Administer a 2-dose series of varicella vaccine 4-8 weeks apart if no evidence of immunity exists. 2
- Evidence of immunity includes U.S. birth before 1980 (except for healthcare personnel), documentation of vaccination, laboratory confirmation, or physician-diagnosed disease. 2
Human Papillomavirus (HPV)
- Give a 3-dose series of HPV vaccine at 0,1-2, and 6 months for both males and females through age 26 years. 2
- For males specifically, the schedule shows 3 doses through age 21 years as routine, with catch-up through age 26. 2
Risk-Based Vaccines to Assess
Hepatitis A
- Administer a 2-dose series if the patient has any of these risk factors: 2
- Men who have sex with men
- Injection or non-injection drug use
- Chronic liver disease
- Homelessness
- Travel to endemic countries
- Close contact with international adoptees from endemic areas
Meningococcal Vaccines
Give meningococcal conjugate vaccine (MenACWY) if the patient: 2
- Lives in college dormitories or military barracks
- Has functional or anatomic asplenia
- Has complement deficiencies or HIV infection
- Is a microbiologist routinely exposed to Neisseria meningitidis
- Travels to hyperendemic areas
Consider meningococcal B vaccine (MenB) based on individual clinical decision for healthy adolescents and young adults aged 16-23 years (preferred age 16-18). 2
Critical Implementation Points
Approach to Missing Records
- Never delay vaccination to search for records or obtain serologic testing for most vaccines. 1
- The standard approach is to administer all indicated vaccines immediately, as giving extra doses to previously immune individuals is safe. 1
- The only exception where serology may be considered is for varicella in adults with uncertain history, but vaccination without testing is still acceptable. 2
Vaccine Administration
- All indicated vaccines can be administered simultaneously at the same visit. 3
- Use separate anatomic sites for different injections. 3
- Minimum intervals between doses must be respected, but longer intervals do not reduce effectiveness. 3
Common Pitfalls to Avoid
- Do not restart vaccine series regardless of time elapsed between doses—simply continue where the patient left off. 3
- Do not withhold vaccines while attempting to locate old records—this delays protection unnecessarily. 1
- Do not assume immunity based on patient recall alone—documentation or laboratory evidence is required. 2
- Do not give live vaccines (MMR, varicella, LAIV) to pregnant women or severely immunocompromised patients. 2
Special Considerations for This Age Group
- If the patient is a healthcare worker, ensure 2 doses of MMR and varicella regardless of birth year. 2
- If the patient is or becomes pregnant, administer Tdap during each pregnancy at 27-36 weeks gestation. 2, 3
- If the patient has any immunocompromising conditions, complete all indicated vaccines at least 2 weeks before starting immunosuppressive therapy when possible. 1